|
Market Closed -
Other stock markets
|
After hours 07:52:45 pm | |||
| 25.65 USD | -0.93% |
|
25.76 | +0.41% |
| Jan. 16 | Pfizer-backed Agomab Therapeutics reveals wider loss in US IPO filing | RE |
| Jan. 16 | Agomab Therapeutics files for US IPO - SEC filing | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- PFE Stock
- Consensus Pfizer Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
